Quest Diagnostics Shares Outstanding 2010-2025 | DGX

Quest Diagnostics shares outstanding for the quarter ending March 31, 2025 were 113M, a 0.89% increase year-over-year.

  • Quest Diagnostics 2024 shares outstanding were 0.113B, a 0% decline from 2023.
  • Quest Diagnostics 2023 shares outstanding were 0.113B, a 4.24% decline from 2022.
  • Quest Diagnostics 2022 shares outstanding were 0.118B, a 7.81% decline from 2021.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Quest Diagnostics Shares Outstanding 2010-2025 | DGX

  • Quest Diagnostics 2024 shares outstanding were 0.113B, a 0% decline from 2023.
  • Quest Diagnostics 2023 shares outstanding were 0.113B, a 4.24% decline from 2022.
  • Quest Diagnostics 2022 shares outstanding were 0.118B, a 7.81% decline from 2021.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Encompass Health (EHC)$11.1B
DaVita (DVA)$10.7B
Elanco Animal Health (ELAN)$7.3B
Chemed (CHE)$6.6B
Option Care Health (OPCH)$4.8B
RadNet (RDNT)$4.3B
Amedisys (AMED)$3.2B
Addus HomeCare (ADUS)$2B
LifeStance Health (LFST)$1.6B
Astrana Health (ASTH)$1.3B
U.S Physical Therapy (USPH)$1.1B
Pennant (PNTG)$808M
Aveanna Healthcare Holdings (AVAH)$773M
Atai Life Sciences (ATAI)$647M
Daxor (DXR)$44M
MEDIROM Healthcare Technologies (MRM)$39M
Ontrak (OTRK)$2M
Psychemedics (PMD)$0M